# OnCo record joseph-connors (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/joseph-connors/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "joseph-connors" ;
  schema:name "Joseph M. Connors"@en ;
  schema:description "Led ECHELON-1, which replaced bleomycin with brentuximab vedotin in first-line advanced Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/people/joseph-connors/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Connors%20JM%5BAuthor%5D%20Hodgkin%20brentuximab> ;
  onco:tag "hodgkin", "adc", "canada" ;
  schema:jobTitle "Clinical Professor Emeritus, BC Cancer Centre for Lymphoid Cancer, University of British Columbia" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:institutions <https://onco.cc/institutions/bc-cancer/> ;
  onco:trials <https://onco.cc/trials/echelon-1/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-echelon-1-brentuximab-avd-nejm-2018/> ;
  schema:affiliation <https://onco.cc/institutions/bc-cancer/> .